A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients

Clinical trial NCT01266005 · TERMINATED

Trial details

NCT number: NCT01266005
Sponsor: Bukwang Pharmaceutical
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2009-08-01
Primary completion: 2013-08-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.